Literature DB >> 6357335

Captopril potentiates the vasodepressor action of Met-enkephalin in the anaesthetized rat.

R Di Nicolantonio, J S Hutchinson, Y Takata, M Veroni.   

Abstract

The transient vasodepressor action of Met-enkephalin (10-80 micrograms kg-1, i.v.) in anaesthetized rats was significantly potentiated by the angiotensin-converting enzyme inhibitor, captopril (2 mg kg-1, i.v.); at this dose, it failed to modify the transient vasodepressor action of the non-specific vasodilator, nitroprusside (2.5, 5.0, 10 micrograms kg-1, i.v.). Captopril (2 mg kg-1, i.v.) caused a slow, progressive fall in the blood pressure of anaesthetized spontaneously hypertensive (SH) rats when compared to vehicle-treated controls. Pretreatment with naloxone (1.5 mg kg-1, i.v.) 30 min earlier failed to alter significantly the hypotensive action of captopril in anaesthetized SH rats. It was concluded that although captopril potentiated the vasodepressor action of Met-enkephalin in anaesthetized normotensive rats, potentiation of endogenous opioids does not appear to be involved in the hypotensive action of captopril in anaesthetized SH rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357335      PMCID: PMC2045003          DOI: 10.1111/j.1476-5381.1983.tb10709.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Co-identity of brain angiotensin converting enzyme with a membrane bound dipeptidyl carboxypeptidase inactivating Met - enkephalin.

Authors:  M Benuck; N Marks
Journal:  Biochem Biophys Res Commun       Date:  1979-05-14       Impact factor: 3.575

2.  'Enkephalinase' is distinct from brain 'angiotensin-converting enzyme'.

Authors:  J P Swerts; R Perdrisot; G Patey; S De La Baume; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1979-08-01       Impact factor: 4.432

Review 3.  Angiotensin-converting enzyme and the regulation of vasoactive peptides.

Authors:  R L Soffer
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

4.  Hydrolysis of bradykinin by angiotensin-converting enzyme.

Authors:  F E Dorer; J R Kahn; K E Lentz; M Levine; L T Skeggs
Journal:  Circ Res       Date:  1974-06       Impact factor: 17.367

Review 5.  Effects of captopril in animal models of hypertension.

Authors:  M J Antonaccio; B Rubin; Z P Horovitz
Journal:  Clin Exp Hypertens       Date:  1980       Impact factor: 1.749

6.  Cardiovascular effects of peptides related to the enkephalins and beta-casomorphin.

Authors:  E T Wei; A Lee; J K Chang
Journal:  Life Sci       Date:  1980-05-05       Impact factor: 5.037

7.  Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase.

Authors:  E G Erdös; A R Johnson; N T Boyden
Journal:  Biochem Pharmacol       Date:  1978-03-01       Impact factor: 5.858

8.  Effects of intravenously administered Leu- or Met-enkephalin on arterial blood pressure.

Authors:  R H Moore; D A Dowling
Journal:  Regul Pept       Date:  1980-10

9.  Hypotensive effect of [Sar1,Thr8]angiotensin II in spontaneously hypertensive sodium-depleted rats.

Authors:  H Muñoz-Ramírez; M C Khosla; F M Bumpus; P A Khairallah
Journal:  Am J Physiol       Date:  1978-04

10.  Hypotensive effects of captopril administered centrally in intace conscious spontanously hypertensive rats and peripherally in anephric anaesthetized spontaneously hypertensive rats.

Authors:  J S Hutchinson; F A Mendelsohn
Journal:  Clin Exp Pharmacol Physiol       Date:  1980 Sep-Oct       Impact factor: 2.557

View more
  3 in total

1.  Captopril and opiate antagonism in essential hypertension.

Authors:  A A Ajayi; P C Rubin; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

2.  Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients.

Authors:  G P Bernini; A R Lucarini; M S Vivaldi; C Del Corso; M Lenzi; A Salvetti
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

3.  Naloxone as an antidote for angiotensin converting enzyme inhibitor poisoning: a case report.

Authors:  Vatsal Trivedi; Bryan A Glezerson; Dipayan Chaudhuri; Morgan Davidson; Ghislaine Douflé
Journal:  Can J Anaesth       Date:  2020-04-27       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.